Technical Report

El impacto de los servicios sanitarios sobre la salud

Report number: Working Paper No. 752., Affiliation: Universitat Pompeu Fabra Economics and Business
Source: OAI

ABSTRACT This paper reviews what has increased medical-care spending bought in terms of health benefits with longitudinal data from the U.S and, more limited, from Spain. Health services contribution to health has been positive in average, especially during the last 50 years for the U.S and the last 30 years for Spain. This contribution differs among countries and is much greater for some diseases (cardiovascular) than for others (cancer). Benefits from health care interventions can be valued on basis on the social willin gness to pay, observed or declared on the process of establishing health policy priorities. 30.000 euros per Quality Adjusted Life Year could provide an efficiency threshold for financing publicly health services in Spain: Consensus and legitimacy of the political process of establishing health priorities becomes, however, more important than any approximate number. Attention is paid finally to bridging the gap between efficacy (the possibilities given by innovation and resources devoted to health care) and effectiveness (the distance to the frontier) of the everyday working of a health system with its inappropriate care and limited application of the existing knowledge.

Download full-text


Available from: Vicente Ortún-Rubio, Aug 18, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: The populations of New Haven and Boston are demographically similar and receive most of their hospital care in university hospitals, but in 1982 their expenditures per head for inpatient care were $451 and $889, respectively. The 685,400 residents of Boston incurred about $300 million more in hospital expenditures and used 739 more beds than they would have if the use rates for New Haven residents had applied. Most of the extra beds were invested in higher admission rates for medical conditions in which the decision to admit can be discretionary. The overall rates for major surgery were equal, but rates for some individual operations varied widely. These findings indicate that academic standards of care are compatible with widely varying patterns of practice and that medical care costs are not necessarily high in communities served largely by university hospitals. They also emphasise the need for increased attention to the outcome and cost implications of differences in practice styles.
    The Lancet 06/1987; 1(8543):1185-9. DOI:10.1016/S0140-6736(87)92152-0 · 45.22 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Introducción: A pesar del creciente reconocimiento de la potencial utilidad de los estudios de coste-efectividad, en España no existe ningún criterio que permita establecer si una determinada tecnología sanitaria puede considerarse rentable o no. El objetivo de este trabajo es describir cuáles han sido los límites y criterios utilizados en España para recomendar la adopción o el rechazo de intervenciones sanitarias en función de su coste-efectividad. Método: Se realizó una revisión de las evaluaciones económicas de intervenciones sanitarias publicadas en España desde 1990 hasta 2001. Se seleccionaron las evaluaciones económicas completas en las que el cociente coste-efectividad se había expresado como coste por año de vida ganado (AVG), como coste por año de vida ajustado por calidad (AVAC) o como coste por vida salvada. Se analizaron las intervenciones sobre las que los autores establecieron algún tipo de recomendación (de adopción o rechazo), así como los criterios utilizados. Resultados: Veinte (20%) de las 100 evaluaciones económicas completas publicadas cumplieron con los criterios señalados. En 16 de los estudios, los resultados se expresaron como coste por AVG, en 6 como coste por AVAC y en 1 como coste por vida salvada. Se evaluaron un total de 82 intervenciones sanitarias, en 44 de las cuales se realizó algún tipo de recomendación. Los autores recomendaron la adopción de todas las intervenciones sanitarias con un coste-efectividad inferior a 30.000 euros (5 millones de pesetas) por AVG. Por encima de esa cifra no se apreció ninguna tendencia. Conclusiones: Si bien los resultados deben ser interpretados con mucha precaución, dadas las limitaciones del estudio, los límites de coste-efectividad presentados en este trabajo podrían constituir una primera referencia a lo que podría considerarse como una intervención sanitaria eficiente en España.
    Gaceta Sanitaria 01/2002; 16(4). DOI:10.1016/S0213-9111(02)71933-X · 1.25 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A framework for organizing health services data is presented that subdivides the spectrum of health information into subgroups that constitute a logical progression from quantifying the burden of illness, through identifying its likely causes, to validating interventions that prevent or ameliorate it and evaluating their efficiency, to monitoring the application of these interventions and coming full-circle to determine whether the burden of illness has been reduced.
    Journal of Chronic Diseases 02/1985; 38(4):339-51. DOI:10.1016/0021-9681(85)90080-3